Potassium Ion

Potassium Ion

SCHEMBL2563944

CC=CC=CC=CC(=O)[O-].[K+]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
CA4 P22748 2/20 0.38
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
CNR2 P34972 8/20 0.35
CNR1 P21554 6/20 0.35
BBOX1 O75936 1/20 0.34
PPARG P37231 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
TRPA1 O75762 2/20 0.31
RAB9A P51151 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2563941 1.00 ALDH1A1 (0.39) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL3641 0.97
Sorbic Acid SCHEMBL29573362 0.97 CA4 (0.40) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL3640 0.97
Sorbic Acid SCHEMBL929156 0.97 CA4 (0.40) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL929158 0.97 CA4 (0.40) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL7567295 0.95 CA4 (0.38) ALDH1A1CA4CA1CA9CNR2
SCHEMBL416205 0.95 ALDH1A1 (0.39) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL5328357 0.95 CA4 (0.43) ALDH1A1CA4CA1CA9CNR2
Sorbic Acid SCHEMBL30195487 0.95 CA4 (0.43) ALDH1A1CA4CA1CA9CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041459-B1 COMPOSITIONS USEFUL IN THE PREVENTION OR TREATMENT OF SKIN CANCER GIULIANI SPA (IT) 2019-04-03 EP claimed
EP-3041459-A1 COMPOSITIONS USEFUL IN THE PREVENTION OR TREATMENT OF SKIN CANCER Giuliani S.p.A. (IT) 2016-07-13 EP claimed
WO-2015033276-A1 COMPOSITIONS USEFUL IN THE PREVENTION OR TREATMENT OF SKIN CANCER GIULIANI S.P.A. (IT) 2015-03-12 WO claimed
EP-3490680-B1 TOPICAL COSMETIC COMPOSITION FOR RESTRUCTURING AND PROTECTING HAIR AND SCALP, AND USES THEREOF KEMON S P A (IT) 2025-11-19 EP disclosed
EP-4464307-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-20 EP disclosed
US-20240374498-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-14 US disclosed
US-9289405-B2 Compounds provided with antioxidant activity against free radicals, and pharmaceutical and cosmetic compositions containing them GIULIANI S.P.A (IT) 2016-03-22 US disclosed
EP-2560632-B1 COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI SPA (IT) 2014-10-29 EP disclosed
EP-2560632-A1 COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM Giuliani S.p.A. (IT) 2013-02-27 EP disclosed
US-20130046017-A1 COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2013-02-21 US disclosed
WO-2011132177-A1 COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM GIULIANI S.P.A. (IT) 2011-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130046017-A1 COMPOUNDS PROVIDED WITH ANTIOXIDANT ACTIVITY AGAINST FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM LPO, CAT, TYR ALDH1A1 197/4885CA4 1132/4885CA1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.